Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHL2300031	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2023-02-21		F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd			view
JXHB2200052	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2022-04-24		F Hoffmann-La Roche Ltd(Switzerland)			view
JXHL2400225	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2024-09-25		F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd			view
JXHL2200343	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2022-12-07		F Hoffmann-La Roche Ltd(Switzerland)			view
JXHB2101043	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2021-08-03		F Hoffmann-La Roche Ltd(Switzerland)			view
JXHB2400033	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2024-02-06		F Hoffmann-La Roche Ltd(Switzerland)			view
JXHL2200344	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2022-12-07		F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd			view
JXHB2101044	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2021-08-03		F Hoffmann-La Roche Ltd(Switzerland)			view
JXHB2400034	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2024-02-06		F Hoffmann-La Roche Ltd(Switzerland)			view
JXHL2400226	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2024-09-25		F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd			view
JXHL2300029	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2023-02-21		F Hoffmann-La Roche Ltd(Switzerland)			view
JXHB2200053	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2022-04-24		F Hoffmann-La Roche Ltd(Switzerland)			view
JXHB2000053	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2020-11-23	罗氏（中国）投资有限公司	Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland)	In Review	2020-11-21	view
JXHL2000149	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2020-06-30	罗氏（中国）投资有限公司	Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland)	In Review	2020-06-29	view
JXHL2000172	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2020-07-03	罗氏（中国）投资有限公司	Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland)	In Review	2020-07-02	view
JXHL2000171	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2020-07-03	罗氏（中国）投资有限公司	Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland)	In Review	2020-07-02	view
JXHB2000052	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Supplementary Application	2020-11-23	罗氏（中国）投资有限公司	Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland)	In Review	2020-11-21	view
JXHL2000148	GDC-0077	inavolisib	Active ingredient	Chemical Drugs(1)	Import Drug Application	2020-06-30	罗氏（中国）投资有限公司	Roche (China) Holding Ltd;F Hoffmann-La Roche Ltd(Switzerland)	In Review	2020-06-29	view